hVIVO plc (LON:HVO – Get Free Report)’s stock price shot up 10% on Monday . The stock traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). 7,804,669 shares traded hands during trading, an increase of 164% from the average session volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Stock Up 10.0 %
The business has a fifty day moving average price of GBX 20.25 and a two-hundred day moving average price of GBX 25.68. The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86. The company has a market cap of £144.58 million, a price-to-earnings ratio of 708.33 and a beta of 0.97.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
- Five stocks we like better than hVIVO
- 3 Monster Growth Stocks to Buy Now
- Sizing Up a New Opportunity for NVIDIA Investors
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Best Stocks Under $10.00
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
